This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
over 18
years old
2
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The study purpose is to observe which neoadjuvant chemotherapy regimens is the better for invasive breast cancer. The neoadjuvant chemotherapy regimen is sustained anthracyclines plus taxanes or from anthracyclines plus taxanes to vinorelbine plus cisplatinum.
Tris trial is registered with FDA with number: NCT01732939. The sponsor of the trial is Hospital Affiliated to Military Medical Science, Beijing and it is looking for 60 volunteers for the current phase.
Official trial title: